1.
Inflamm Bowel Dis
; 2023 Dec 23.
Article
in English
| MEDLINE
| ID: mdl-38142124
ABSTRACT
We present a case series of 16 patients with ulcerative colitis who received upadacitinib after failing tofacitinib. Five patients (36%) achieved steroid-free clinical remission. Five (62%) demonstrated endoscopic response, while 2 patients (25%) achieved endoscopic remission. Adverse events were low.